November 21, 2025 16:30 ET | Source: Teva Pharmaceutical Industries Ltd TEL AVIV, Israel, Nov. 21, 2025 (GLOBE NEWSWIRE) --…
The company is redefining application security and AI Runtime Protection through its pioneering Application Detection and Response (ADR) platform for…
Of the 209 patients with tardive dyskinesia (TD) that were surveyed, >94% reported movement improvement once treated with AUSTEDO XR®…
Strategic Hires Underscore Momentum as Company Expands Global Commercialization of Long-Range Wireless Power TEL AVIV, Israel, Aug. 7, 2025 /PRNewswire/…
TEL AVIV, Israel, July 02, 2025 (GLOBE NEWSWIRE) -- Radware® (NASDAQ: RDWR), a global leader in application security and delivery…
TEL AVIV, Israel, June 10, 2025 (GLOBE NEWSWIRE) -- LightSolver, inventors of a new laser-based computing paradigm, and HLRS (High-Performance…
TEL AVIV, Israel, June 9, 2025 /PRNewswire/ -- Microtech, a wholly owned subsidiary of Medinol, is happy to announce the…
June 05, 2025 16:31 ET | Source: ImPact Biotech – Previously inoperable patient converted to eligible for resection, underwent pancreaticoduodenectomy,…
More than half of residents with tardive dyskinesia (TD) residing in long-term care (LTC) settings do not receive standard of…
Real-world claims studies evaluating UZEDY® (risperidone) also show improved adherence and persistence rates, fewer inpatient, outpatient and emergency department (ED)…